US stock movement | Pfizer (PFE.US) rises over 4% Q2 revenue and profit exceed expectations

According to the Securities Times app, on Tuesday, Pfizer (PFE.US) rose more than 4% to $24.52. Pfizer released its second-quarter financial report, with second-quarter revenue at $14.7 billion, higher than the expected $13.47 billion; earnings per share were $0.78, higher than the expected $0.57. Strong demand for heart disease drug Vyndaqel and anticoagulant Eliquis has led to revenue and profits exceeding expectations.